February 27, 2015 5:48 PM ET


Company Overview of Baxter Hemoglobin Therapeutics, Inc.

Company Overview

As of May 4, 1998, Somatogen, Inc. was acquired by Baxter International Inc. Previously, Somatogen, Inc., a biopharmaceutical company, developed specialty oxygen therapeutics and other pharmacological agents utilizing its proprietary recombinant hemoglobin technology.

2545 Central Ave

Suite Fdi

Boulder, CO 80301

United States

133 Employees



Key Executives for Baxter Hemoglobin Therapeutics, Inc.

Baxter Hemoglobin Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Response Scientific, Inc. United States
STC Biologics, Inc. United States
HK Pharmaceuticals Inc. United States
Giant Funding Corp. United States
Traverse Biosciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Baxter Hemoglobin Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.